Cell Therapeutics (CTIC) traded up 2.67% on Thursday, hitting $1.345. Cell Therapeutics (CTIC) has a 1-year low of $1.14 and a 1-year high of $7.40. The stock’s 50-day moving average is currently $1.42. The company’s market cap is $71.2 million.
Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.